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On November 3, 2018, the Utah Department of Health 
(UDOH) was notified of a suspected human rabies case in 
a man aged 55 years. The patient’s symptoms had begun 
18 days earlier, and he was hospitalized for 15 days before 
rabies was suspected. As his symptoms worsened, he received 
supportive care, but he died on November 4. On November 7, 
a diagnosis of rabies was confirmed by CDC. This was the 
first documented rabies death in a Utah resident since 1944. 
This report summarizes the patient’s clinical course and the 
subsequent public health investigation, which determined that 
the patient had handled several bats in the weeks preceding 
symptom onset. Public health agencies, in partnership with 
affected health care facilities, identified and assessed the risk 
to potentially exposed persons, facilitated receipt of postexpo-
sure prophylaxis (PEP), and provided education to health care 
providers and the community about the risk for rabies associ-
ated with bats. Human rabies is rare and almost always fatal. 
The findings from this investigation highlight the importance 
of early recognition of rabies, improved public awareness of 
rabies in bats, and the use of innovative tools after mass rabies 
exposure events to ensure rapid and recommended risk assess-
ment and provision of PEP.
Case Report
On October 17 and 18, 2018, a man aged 55 years who lived 
in Utah sought chiropractic treatment in Idaho for neck and 
arm pain thought to be caused by a recent work-related injury. 
On October 19, he was evaluated in the emergency department 
of hospital A for continued neck pain, nuchal muscle spasms, 
burning sensation in his right arm, and numbness in the palm 
of his right hand. He had no fever, chills, or other symptoms 
of infection. Dehydration was a concern because the patient 
reported he was unable to drink liquids because of severe pain 
and muscle spasms. The patient received a prescription for a 
steroid for muscle spasms and decreased sensation in the right 
arm and was discharged home.
Two days later, on October 20, the patient developed short-
ness of breath, tachypnea, and lightheadedness and reported 
he had not been able to sleep for 4 days; he was transported by 
ambulance to hospital B. The patient continued to have right 
upper extremity pain and severe esophageal spasms, causing 
him to refuse oral fluids. Because of his worsening symptoms 
and acute delirium, he was transferred to hospital C.
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On October 21, the patient was intubated for airway protec-
tion. His symptoms worsened, with fever to 104.7°F (40.4°C), 
and he became comatose on October 25. Additional exposure 
history collected from family members included ownership 
of two healthy dogs and a healthy horse, and a recent grouse-
hunting trip where the patient had dressed and cleaned the 
birds while wearing gloves. High-dose corticosteroid treat-
ment was initiated for presumed autoimmune encephalitis. 
Because of refractory seizures beginning on October 26, he 
was transferred to hospital D on October 28, where steroids 
were continued. On November 3, an infectious disease physi-
cian was consulted at hospital D who noted that the patient’s 
symptom of spasms when swallowing suggested a possible 
diagnosis of rabies. When specifically questioned about the 
patient’s exposure to wild animals, family members reported 
extensive contact with bats that had occupied the patient’s 
home in the weeks before illness onset. The physician notified 
UDOH, which recommended collecting clinical specimens, 
including skin, saliva, cerebral spinal fluid (CSF), and serum. 
Rabies PEP was not indicated because of the advanced state 
of disease (1). The patient continued to decline, supportive 
care was withdrawn, and he died on November 4, 19 days 
after symptom onset.
On November 7, antemortem specimens (serum, CSF, 
skin biopsy, and saliva) were sent to CDC for testing. CDC 
reported detection of rabies immunoglobulin M and immu-
noglobulin G in the CSF by indirect immunofluorescence 
assay. Rabies virus neutralizing antibodies were detected in 
serum (titer = 1:5,400; 43.2 IU/ml) and in CSF (titer = 1:250; 
2.0 IU/ml), by rapid fluorescent focus inhibition test. No rabies 
virus antigen was detected in skin biopsy by direct fluorescent 
antibody (DFA) test, and no viral RNA was detected in skin 
and saliva by real-time reverse transcription–polymerase chain 
reaction (RT-PCR) (2,3).
CDC confirmed the presence of rabies virus antigen and 
RNA in postmortem brain stem tissue and cerebellum speci-
mens by DFA and real-time RT-PCR, respectively. Antigenic 
typing with monoclonal antibodies to the rabies virus nucleo-
protein, and phylogenetic sequence analysis indicated that the 
virus identified in the patient’s specimens was consistent with 
that of a rabies virus variant associated with Mexican free-tailed 
bats (Tadarida brasiliensis).
Public Health Response
Once the rabies diagnosis was confirmed, UDOH estab-
lished an Incident Command System structure to develop 
and coordinate response activities. The goals of the response 
were to 1) determine the source of the patient’s infection; 
2) identify possible exposure risk to hospital workers, com-
munity members, and family members during the patient’s 
infectious period; 3) coordinate administration of PEP for 
exposed persons; and 4) educate health care providers and the 
public about the risk for rabies associated with contact with 
bats. Public health investigation and response partners included 
the Central Utah Public Health Department, Utah County 
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Summary
What is already known about this topic?
Human rabies is preventable by early recognition of exposure 
and receipt of postexposure prophylaxis (PEP). Bats are the 
main source of rabies in the United States.
What is added by this report?
Delayed recognition of a human rabies case resulted in 
potential exposure of 279 health care workers and others in 
Utah. Exposures were evaluated through an online survey; 74 
health care workers with likely rabies virus exposures and 30 
family and community members who had contact with the 
patient’s body fluids received PEP.
What are the implications for public health practices?
Educating the general public about the risk for rabies through 
bat exposure and advising health care providers to consider 
rabies in the differential diagnosis of unexplained neurologic 
symptoms could reduce exposures.
Health Department, Salt Lake County Health Department, 
Utah Public Health Laboratory, Utah Office of the Medical 
Examiner, Utah Poison Control Center, Idaho Department of 
Health, and affected health care facilities, with epidemiologic 
assistance from CDC. Press briefings were held to provide 
education and awareness to the general public regarding contact 
with bats, the risk for rabies, and the importance for persons 
who had contact with the patient to contact a health care pro-
vider or local health department to assess their need for PEP.
The patient’s family reported that, beginning in August, a 
large number of bats had occupied their attic and frequently 
were found in the living area of the home, particularly in 
the master bedroom. On multiple occasions, the patient had 
removed bats from the home with his bare hands, and on 
one occasion, the patient awoke to find a bat near his head. 
In September, a dead bat was found on the floor of the bed-
room. Despite the substantial bat contact, no bites were noted. 
Family members were not aware of health issues related to 
bat exposure and did not recognize the need to receive rabies 
PEP after touching bats. After rabies was diagnosed, family 
members who spent time with the patient were provided 
PEP. After the patient’s death, to prevent further exposures in 
the home, a professional bat removal company assessed the 
patient’s home and sealed all openings that posed a threat for 
future bat colonization.
The patient’s infectious period was estimated to have begun 
on October 2, 2 weeks before first symptom onset. Because of 
the prolonged hospitalization before the rabies diagnosis was 
made and the number of health care entities involved in the 
patient’s care, UDOH and health care partners conducted an 
extensive investigation to identify possible exposures during 
the patient’s infectious period. To efficiently assess potentially 
exposed health care workers, an online exposure assess-
ment tool, modeled after a tool used in a mass bat exposure 
response in Virginia (4) was developed and distributed to the 
four affected health care facilities. Responses were collected 
at UDOH and provided to the health care facilities, which 
subsequently ensured that exposed employees received PEP 
according to Advisory Committee on Immunization Practices 
guidelines (5). The affected health care facilities identified and 
assessed 242 health care workers known to have had some 
contact with the patient, which included personnel at each 
hospital facility, emergency medical transport services, and 
laboratory workers. A total of 126 (52%) of the 242 exposed 
health care workers completed the online assessment within 
72 hours, and 222 (90%) completed it within 12 days. Among 
the 242 assessed facility-based health care workers with some 
contact with the patient, 74 (31%) were determined to have 
been potentially exposed to infectious materials and received 
PEP; 63 (85%) of the 74 received PEP within 1 week of initial 
assessment. The chiropractic workers who initially evaluated 
the patient were surveyed separately using paper assessment 
forms; none of the workers were found to have been exposed.
In addition to the 242 potentially exposed facility-based 
health care workers, public health officials also assessed 37 
family and community members who had contact with the 
patient (total persons assessed = 279); 30 (81%) of the 37 fam-
ily and community members had contact with the patient’s 
body fluids and received PEP. The PEP supply used during 
the response was coordinated and administered by health care 
facilities throughout Utah. All exposed health care workers 
completed the PEP regimen as scheduled with only one report 
of an adverse reaction to the rabies vaccine (gastrointestinal 
illness reported by one health care provider after receipt of the 
third vaccine dose).
In April 2019, CDC and UDOH conducted focus group dis-
cussions with local health departments involved in the response 
and with health care workers who cared for the patient. The 
discussions revealed knowledge gaps about human-to-human 
rabies transmission among health care workers, and rabies 
prevention among animal control workers and community 
members. In response, UDOH and CDC delivered a hospital 
presentation in hospital D, which was broadcast to hospitals A, 
B, and C and across the health care system to health care work-
ers in urban and rural areas. Posters and fliers describing the risk 
for rabies associated with bats were distributed by local public 
health workers to animal health workers, health care facilities, 
public health offices, and other public locations.
Discussion
Human rabies deaths are rare in the United States, and early 
recognition of the disease can reduce the number of health 
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care–associated exposures and ensure timely receipt of PEP 
(3). Considerations for early recognition include providing 
education to medical providers (especially those in rural areas) 
regarding clinical symptoms, identifying patient exposures to 
wild animals such as bats, and emphasizing the importance 
of PEP if an exposure occurs. In Utah, humans and animals 
are most likely to be infected with rabies through exposure to 
bats, the only known rabies reservoir in Utah.* The Mexican 
free-tailed bat is the most common host species detected in 
Utah through public health surveillance (42% of all bats) fol-
lowed by the Big Brown (21%) and the Silver Haired (15%).
During the past 10 years, an average of 95 bats per year 
were submitted to the Utah Public Health Laboratory for 
testing, with 15–25 bats found to be rabid; however, this only 
accounts for bats tested through the state laboratory and does 
not count all bats in Utah. The delayed diagnosis of rabies in 
the patient in this report prevented him from receiving any 
early treatment for rabies and also resulted in potential rabies 
exposures for 279 persons in multiple settings during the 
patient’s infectious period. Structured collaboration between 
public health partners and health care facilities, as well as the 
use of online exposure assessment, permitted rapid assessment 
of exposed persons across numerous settings, facilitating timely 
recommendation and administration of PEP.
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